- This event has passed.
NEALS Webinar: Tofersen Update
May 2, 2023 @ 4:00 pm - 4:45 pm EDT
Free
|
NEALS Webinar: Tofersen Update |
|
|
|
|
|
|
|
Tuesday, May 2, 2023 The U.S. Food and Drug Administration (FDA) has granted accelerated approval for tofersen for the treatment of individuals with superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). Join Dr. Timothy Miller for a webinar update following the FDA’s recent announcement moderated by NEALS Co-Chairs Dr. Jinsy Andrews and Dr. James Berry. |
|
|
|
